Adjuvant Embolization With N-Butyl Cyanoacrylate in the Treatment of Cerebral Arteriovenous Malformations Outcomes, Complications, and Predictors of Neurologic Deficits

被引:75
|
作者
Starke, Robert M.
Komotar, Ricardo J.
Otten, Marc L.
Hahn, David K. [2 ]
Fischer, Laura E.
Hwang, Brian Y.
Garrett, Matthew C.
Sciacca, Robert R.
Sisti, Michael B.
Solomon, Robert A.
Lavine, Sean D. [3 ]
Connolly, E. Sander
Meyers, Philip M. [1 ,3 ]
机构
[1] Columbia Univ, Dept Neurosurg, Neurol Inst, New York, NY 10032 USA
[2] Northwestern Univ, Dept Neurosurg, Chicago, IL 60611 USA
[3] Columbia Univ, Dept Intervent Neuroradiol, New York, NY 10032 USA
关键词
arteriovenous malformation; complication; embolization; outcome; surgery; PREOPERATIVE EMBOLIZATION; ENDOVASCULAR TREATMENT; GRADING SYSTEM; STEREOTAXIC RADIOSURGERY; SURGICAL-MANAGEMENT; BASAL GANGLIA; BRAIN; EXPERIENCE; DETERMINANTS; SURGERY;
D O I
10.1161/STROKEAHA.108.539775
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-The purpose of this study was to assess the frequency, severity, and predictors of neurological deficits after adjuvant embolization for cerebral arteriovenous malformations. Methods-From 1997 to 2006, 202 of 275 patients with arteriovenous malformation received embolization before microsurgery (n = 176) or radiosurgery (n = 26). Patients were examined before and after endovascular embolization and at clinical follow-up (mean, 43.4 +/- 34.6 months). Outcome was classified according to the modified Rankin Scale. New neurological deficits after embolization were defined as minimal (no change in overall modified Rankin Scale), moderate (modified Rankin Scale <= 2), or significant (modified Rankin Scale > 2). Results-Two hundred two patients were treated in 377 embolization procedures. There were a total of 29 new clinical deficits after embolization (8% of procedures; 14% of patients), of which 19 were moderate or significant. Postembolization deficits resolved in a significant number of patients over time (P < 0.0001). Five patients had persistent neurological deficits due to embolization (1.3% of procedures; 2.5% of patients). In multivariate analysis, the following variables significantly predicted new neurological deficit after embolization: complex arteriovenous malformation with treatment plan specifying more than one embolization procedure (OR, 2.7; 95% CI, 1.4 to 8.6), diameter < 3 cm (OR, 3.2; 95% CI, 1.2 to 9.1), diameter > 6 cm (OR, 6.2; 95% CI, 1.0 to 57.0), deep venous drainage (OR, 2.7; 95% CI, 1.1 to 6.9), or eloquent location (OR, 2.4; 95% CI, 1.0 to 5.7). These variables were weighted and used to compute an arteriovenous malformation Embolization Prognostic Risk Score for each patient. A score of 0 predicted no new deficits, a score of 1 predicted a new deficit rate of 6%, a score of 2 predicted a new deficit rate of 15%, a score of 3 predicted a new deficit rate of 21%, and a score of 4 predicted a new deficit rate of 50% (P < 0.0001). Conclusions-Small and large size, eloquent location, deep venous drainage, and complex vascular anatomy requiring multiple embolization procedures are risk factors for the development of immediate postembolization neurological deficits. Nevertheless, a significant number of patients with treatment-related neurological deficits improve over time. The low incidence of permanent neurological deficits underscores the usefulness of this technique in carefully selected patients. (Stroke. 2009; 40: 2783-2790.)
引用
收藏
页码:2783 / 2790
页数:8
相关论文
共 50 条
  • [1] Does treatment with N-butyl cyanoacrylate embolization protect against hemorrhage in cerebral arteriovenous malformations?
    Raupp, EF
    Fernandes, J
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2005, 63 (01) : 34 - 39
  • [2] Embolization of the nidus of brain arteriovenous malformations with n-butyl cyanoacrylate
    Debrun, GM
    Aletich, V
    Ausman, JI
    Charbel, F
    Dujovny, M
    NEUROSURGERY, 1997, 40 (01) : 112 - 120
  • [3] OUTCOME ANALYSIS OF PREOPERATIVE EMBOLIZATION WITH N-BUTYL CYANOACRYLATE IN CEREBRAL ARTERIOVENOUS-MALFORMATIONS
    DEMERITT, JS
    PILESPELLMAN, J
    MAST, H
    MOOHAN, N
    LU, DC
    YOUNG, WL
    HACEINBEY, L
    MOHR, JP
    STEIN, BM
    AMERICAN JOURNAL OF NEURORADIOLOGY, 1995, 16 (09) : 1801 - 1807
  • [4] Dosimetric Measurements of An N-Butyl Cyanoacrylate Embolization Material for Arteriovenous Malformations
    Labby, Z. E.
    Roberts, D. A.
    Chaudhary, N.
    Gemmete, J. J.
    Pandey, A. S.
    MEDICAL PHYSICS, 2013, 40 (06)
  • [5] Dosimetric measurements of an n-butyl cyanoacrylate embolization material for arteriovenous malformations
    Labby, Zacariah E.
    Chaudhary, Neeraj
    Gemmete, Joseph J.
    Pandey, Aditya S.
    Roberts, Donald A.
    MEDICAL PHYSICS, 2015, 42 (04) : 1739 - 1744
  • [7] THE EFFECT OF EMBOLIZATION WITH N-BUTYL CYANOACRYLATE PRIOR TO SURGICAL RESECTION OF CEREBRAL ARTERIOVENOUS-MALFORMATIONS
    JAFAR, JJ
    DAVIS, AJ
    BERENSTEIN, A
    CHOI, IS
    KUPERSMITH, MJ
    JOURNAL OF NEUROSURGERY, 1993, 78 (01) : 60 - 69
  • [8] Embolization of cerebral arteriovenous malformations with N-butyl-2-cyanoacrylate
    Liu, HM
    Huang, YC
    Wang, YH
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2000, 99 (12) : 906 - 913
  • [9] N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: Results of a prospective, randomized, multi-center trial
    Purdy, P
    Horowitz, M
    Kopitnik, T
    Samson, D
    Dion, J
    Joseph, G
    Dawson, R
    Owens, D
    Barrow, D
    Barr, J
    Powers, S
    Cockroft, K
    Holmes, B
    Sumas, M
    Wallace, R
    Masaryk, T
    Perl, J
    Chyatte, D
    Tomsick, T
    Tew, JM
    van Loveren, H
    Zuccarello, M
    Marks, M
    Norbash, A
    Steinberg, G
    Halbach, V
    Higashida, R
    Dowd, C
    Lawton, M
    Wilson, C
    McDougall, C
    Spetzler, R
    Nesbit, G
    Barnwell, S
    Nichols, D
    Thielen, K
    Atkinson, J
    Meyer, F
    Piepgras, D
    Choi, IS
    Day, JD
    Berenstein, A
    Setton, A
    Pryor, J
    Niimi, Y
    Flamm, E
    DeNardo, A
    Scott, J
    Murtagh, FR
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2002, 23 (05) : 748 - 755
  • [10] A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations
    Loh, Yince
    Duckwiler, Gary R.
    JOURNAL OF NEUROSURGERY, 2010, 113 (04) : 733 - 741